Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. | MicrobiomeTrials

← Back to trials

NCT07494305

Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2026-01-23Est. Completion: 2028-02

Enrollment target: 320 participants

Locations

Pillar Clinical Research, Bentonville, Arkansas, United States
Pillar Clinical Research, Little Rock, Arkansas, United States
CenExel, Bellflower, California, United States
ProScience Research Group, Culver City, California, United States
CenExel, Garden Grove, California, United States
Synergy San Diego, Lemon Grove, California, United States
NRC Research Institute, Los Angeles, California, United States
NRC Research Institute, Orange, California, United States
CenExel, Riverside, California, United States
CenExel, Torrance, California, United States
St. Jude Clinical Research, Doral, Florida, United States
Cenexel Hollywood Florida, Hollywood, Florida, United States
Innovative Clinical Research, Miami Lakes, Florida, United States
Health Synergy Clinical Research, West Palm Beach, Florida, United States
Trialmed, Atlanta, Georgia, United States
Cenexel Decatur GA, Decatur, Georgia, United States
Pillar Clinical Research, Chicago, Illinois, United States

Other microbiome trials you might be interested in

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.Phase 3Recruiting

DepressionBipolar I Disorder

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatr…

Bentonville, United StatesEst. completion Mar 2027

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I DisorderPhase 3Recruiting

Bipolar-I Disorder With Mania or Mania With Mixed Features

The purpose of this study is to evaluate the efficacy and safety of KarXT for the treatment of manic episodes in Bipolar…

Bentonville, United StatesEst. completion Nov 1, 2026

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.